000			01496 a2200445 4500
005			20250513105812.0
264		0	_c19970121
008			199701s 0 0 eng d
022			_a0041-1345
040			_aNLM _beng _cNLM
100	1		_aHale, D A
245	0	0	_aProlongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine. _h[electronic resource]
260			_bTransplantation proceedings _cDec 1996
300			_a3270-1 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAbatacept
650	0	4	_aAnimals
650	0	4	_aAntigens, CD
650	0	4	_aAntigens, Differentiation _xtherapeutic use
650	0	4	_aCTLA-4 Antigen
650	0	4	_aCyclosporine _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aGraft Survival _xdrug effects
650	0	4	_aImmunoconjugates
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, Inbred C3H
650	0	4	_aMice, Inbred Strains
650	0	4	_aPolyenes _xtherapeutic use
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aSirolimus
650	0	4	_aSkin Transplantation _ximmunology
650	0	4	_aTime Factors
650	0	4	_aTransplantation, Homologous
700	1		_aGottschalk, R
700	1		_aWood, M L
700	1		_aMaki, T
700	1		_aMonaco, A P
773	0		_tTransplantation proceedings _gvol. 28 _gno. 6 _gp. 3270-1
999			_c8954094 _d8954094